National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
CLORAZEPATE DIPOTASSIUM TABLETS ,
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC51672-4042-02 | 0MLD2 | A | 5 | 2 | 4 | ZZ | ||
| NDC53265-0048-50 | 0E5C1 | A | 3 | 2 | 4 | ZZ | ||
| NDC00047-0451-30 | 2T119 | A | 5 | 9 | 4 | KX | ||
| NDC00074-4389-53 | 70048 | A | 3 | 2 | 6 | 54 | ||
| NDC00378-0030-05 | 60895 | A | 5 | 2 | 4 | ZZ | ||
| NDC00536-4940-05 | 4V824 | H | 5 | 9 | 4 | KX | ||
| TRANXENE TABLETS | 70048 | A | 5 | 1 | 6 | 54 | ||
| NDC00228-3067-50 | 56287 | A | 5 | 2 | 4 | ZZ | ||
| 4389-53 | 70048 | A | 3 | 2 | 6 | 54 | ||
| NDC00591-0363-05 | 62051 | A | 5 | 2 | 4 | ZZ | ||
| NDC00364-2201-05 | 64682 | R | 5 | 9 | 4 | KX | ||
| TRANXENE | 70048 | A | 5 | 1 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 0E5C1 | ABLE LABORATORIES |
| 0MLD2 | TARO PHARMACEUTICALS USA INC |
| 2T119 | WARNER LAMBERT LTD |
| 70048 | ABBOTT LABORATORIES PHARMACEUTICAL P |
| 60895 | MYLAN PHARMACEUTICALS INC |
| 4V824 | RUGBY GROUP INC |
| 56287 | ACTAVIS INC |
| 62051 | DANBURY PHARMACAL INC |
| 64682 | SCHEIN HENRY INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |